CPhI Announces 2014 Expert Panel and Report
CPhI 2014 panel additions to provide global insights from the contract services sector.
CPhI Worldwide has announced its confirmed expert industry panel members for 2014. This year’s panel sees the return of ten thought leaders with the addition of three new members, covering the entire pharmaceutical supply chain from R&D through to finished products, regulatory requirements, and economic implications.
Additionally, this year panel members are using their market insights and analysis year-round in the CPhI Pharma Insights series, which covers individual topics and developments across the industry including the released R&D, manufacturing, and Turkey reports, with a US report due out soon.
The new panel members are all from the contract manufacturing arena, including: Alan Armonstrong, CEO and Douglas Cookson, VP corporate marketing from Almac; Hendrik Baumann, CEO of Arevipharma; and Lukas Utiger, president of fine chemicals and integrated offering at DSM. Collectively they provide a global overview of outsourcing, with Almac and Arevipharma focusing on the international market from a European stance and DSM from a US perspective.
The returning members include Girish Malhotra, Sam Venugopal, Piramal’s Vijay Shah, Hedley Rees, Prabir Basu, Dilip Shah, Emil Ciurczak, and William Botha.
The 2014 annual report features a collection of in-depth essays from each panel member, with experts predicting how the industry will look and operate in the future from both an economic and practical perspective.
Source: CPhI Worldwide
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
